DIN 02380048 · ended Sep 30, 2022 · Disruption of the manufacture of the drug.
Showing 12 of 14 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Fesoterodine. Health Canada has 14 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Fesoterodine is classified under “OTHER UROLOGICALS, INCL ANTISPASMODICS” (ATC G04BD).
Recent changes
Oct 6, 2026
Shortage resolved
Aug 31, 2026
Estimated end date moved earlier : Oct 23, 2026 → Sep 18, 2026
Aug 3, 2026
Estimated end date moved earlier : Dec 10, 2027 → Oct 23, 2026
Jul 13, 2026
Estimated end date pushed back : Jan 29, 2027 → Dec 10, 2027
Common questions
What is Fesoterodine used for?
An antimuscarinic used to treat overactive bladder with urgency and frequent urination.
When will Fesoterodine be back in stock in Canada?
Fesoterodine has no active shortage; supply is normal per Health Canada reports.
Why is Fesoterodine in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.